Roche to pay $2.4 billion to buy rest of Foundation Medicine
June 19, 2018 at 01:38 AM EDT
ZURICH (Reuters) - Swiss drugmaker Roche Holding AG has agreed to pay $137 per share to buy the rest of Foundation Medicine (FMI) , a $2.4 billion transaction that values the U.S. genomic profiling group at $5.3 billion, the partners said on Tuesday.
